Details for New Drug Application (NDA): 210967
✉ Email this page to a colleague
The generic ingredient in DEXAMETHASONE SODIUM PHOSPHATE is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.
Summary for 210967
| Tradename: | DEXAMETHASONE SODIUM PHOSPHATE |
| Applicant: | Eugia Pharma |
| Ingredient: | dexamethasone sodium phosphate |
| Patents: | 0 |
Pharmacology for NDA: 210967
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 210967
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 210967 | ANDA | HF Acquisition Co LLC, DBA HealthFirst | 51662-1541 | 51662-1541-3 | 10 POUCH in 1 CASE (51662-1541-3) / 1 VIAL in 1 POUCH (51662-1541-2) / 10 mL in 1 VIAL (51662-1541-1) |
| DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 210967 | ANDA | Eugia US LLC | 55150-305 | 55150-305-10 | 10 VIAL in 1 CARTON (55150-305-10) / 10 mL in 1 VIAL (55150-305-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10MG PHOSPHATE/ML | ||||
| Approval Date: | Jun 7, 2019 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
